<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04820595</url>
  </required_header>
  <id_info>
    <org_study_id>PoD-2021</org_study_id>
    <nct_id>NCT04820595</nct_id>
  </id_info>
  <brief_title>Postoperative Neurocognitive Dysfunction: Is There Any Place for Emergency Agitation: A Prospective Cohort Trial</brief_title>
  <acronym>PoD</acronym>
  <official_title>Postoperative Neurocognitive Dysfunction: Is There Any Place for Emergency Agitation: A Prospective Cohort Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Negovsky Reanimatology Research Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Negovsky Reanimatology Research Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Perioperative neurocognitive disorders (PND) have been studying by clinicians, particularly&#xD;
      by anesthesiologists, pretty long, however the most inspiring advancements were achieved&#xD;
      during the last few decades. The most recent classification of PND which includes cognitive&#xD;
      decline diagnosed before operation (described as neurocognitive disorder); any form of acute&#xD;
      event (postoperative delirium) and cognitive decline diagnosed up to 30 days after the&#xD;
      procedure (delayed neurocognitive recovery) and up to 12 months (postoperative neurocognitive&#xD;
      disorder) was proposed in 2017. However at will one can notice at least one uncertainty that&#xD;
      pertinent to the definition of delirium, emergency delirium and not mentioned in the&#xD;
      classification discussed agitation.&#xD;
&#xD;
      The objective of the study is to determine if there is a difference between emergence&#xD;
      agitation and emergence delirium.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 30, 2021</start_date>
  <completion_date type="Anticipated">March 29, 2024</completion_date>
  <primary_completion_date type="Anticipated">April 5, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>frequency of postoperative delirium</measure>
    <time_frame>5 postoperative day</time_frame>
    <description>Percent of postoperative delirium</description>
  </primary_outcome>
  <primary_outcome>
    <measure>frequency of postoperative cognitive dysfunction</measure>
    <time_frame>7 postoperative day</time_frame>
    <description>Percent of postoperative cognitive dysfunction</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>frequency of emergence agitation</measure>
    <time_frame>immediately upon emergence from anesthesia</time_frame>
    <description>Percent of emergence agitation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>frequency of emergence delirium</measure>
    <time_frame>immediately upon emergence from anesthesia</time_frame>
    <description>Percent of emergence delirium</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of postoperative delirium</measure>
    <time_frame>5 postoperative day</time_frame>
    <description>Day of the end of postoperative delirium - day of onset of postoperative delirium</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay in ICU</measure>
    <time_frame>1 year</time_frame>
    <description>From ICU admission to ICU discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospitalization</measure>
    <time_frame>1 year</time_frame>
    <description>From operative day to hospital discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MACE</measure>
    <time_frame>30 day</time_frame>
    <description>Cardiac death or Myocardial infarction or Non-fatal cardiac arrest or Coronary revascularization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MACE</measure>
    <time_frame>1 year</time_frame>
    <description>Cardiac death or Myocardial infarction or Non-fatal cardiac arrest or Coronary revascularization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MACCE</measure>
    <time_frame>30 day</time_frame>
    <description>Cardiac death or Myocardial infarction or Non-fatal cardiac arrest or Coronary revascularization or Cerebrovascular accident</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MACCE</measure>
    <time_frame>1 year</time_frame>
    <description>Cardiac death or Myocardial infarction or Non-fatal cardiac arrest or Coronary revascularization or Cerebrovascular accident</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30-day mortality</measure>
    <time_frame>30 day</time_frame>
    <description>30-day mortality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>1-year mortality</measure>
    <time_frame>1 year</time_frame>
    <description>1-year mortality</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">560</enrollment>
  <condition>Emergence Delirium</condition>
  <condition>Emergence Agitation</condition>
  <condition>Postoperative Delirium</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>Patients who have RASS &lt; +2 and have not delirium according CAM-ICU immediately upon emergence from anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Agitated non-delirious group</arm_group_label>
    <description>Patients who have RASS = +2 or more and have not delirium according CAM-ICU immediately upon emergence from anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Agitated delirium group</arm_group_label>
    <description>Patients who have RASS = +2 or more and have delirium according CAM-ICU immediately upon emergence from anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>RASS</intervention_name>
    <description>Richmond Agitation-Sedation Scale</description>
    <arm_group_label>Agitated delirium group</arm_group_label>
    <arm_group_label>Agitated non-delirious group</arm_group_label>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>CAM-ICU</intervention_name>
    <description>Confusion Assessment Method for the ICU</description>
    <arm_group_label>Agitated delirium group</arm_group_label>
    <arm_group_label>Agitated non-delirious group</arm_group_label>
    <arm_group_label>Control group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients from 45 to 74 years old undergoing elective orthopedic surgery&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age from 45 to 74 years&#xD;
&#xD;
          -  Undergoing elective orthopedic surgery&#xD;
&#xD;
          -  Provide written informed consent to participate in the PoD trial&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Undergoing emergent/urgent surgery&#xD;
&#xD;
          -  Montreal Cognitive Assessment &lt; 18 points&#xD;
&#xD;
          -  History of mental disorders according ICD-11&#xD;
&#xD;
          -  Treated with at least one psychotropic drug&#xD;
&#xD;
          -  Patients with neuromuscular disease&#xD;
&#xD;
          -  Inability to undergo preoperative assessment for any reason&#xD;
&#xD;
          -  Previously enrolled in PoD trial&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>74 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Valery Likhvantsev</last_name>
    <role>Principal Investigator</role>
    <affiliation>Negovsky Reanimatology Research Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Valery Likhvantsev</last_name>
    <phone>+7903-623-5982</phone>
    <email>lik0704@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Levan Berikashvili</last_name>
    <phone>+7926-330-89-68</phone>
    <email>levan.berikashvili@mail.ru</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Main Military Clinical Hospital n.a. Acad.N. N. Burdenko</name>
      <address>
        <city>Moscow</city>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valery Likhvantsev</last_name>
      <phone>+7903-623-59-82</phone>
      <email>lik0704@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Levan Berikashvili</last_name>
      <phone>+7926-330-89-68</phone>
      <email>levan.berikashvili@mail.ru</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 23, 2021</study_first_submitted>
  <study_first_submitted_qc>March 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 29, 2021</study_first_posted>
  <last_update_submitted>March 31, 2021</last_update_submitted>
  <last_update_submitted_qc>March 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Negovsky Reanimatology Research Institute</investigator_affiliation>
    <investigator_full_name>Valery Likhvantsev, MD</investigator_full_name>
    <investigator_title>Head of the Research Negovsky Reanimatology Research Institute</investigator_title>
  </responsible_party>
  <keyword>emergence agitation</keyword>
  <keyword>postoperative agitation</keyword>
  <keyword>postoperative delirium</keyword>
  <keyword>postoperative cognitive dysfunction</keyword>
  <keyword>emergence delirium</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
    <mesh_term>Psychomotor Agitation</mesh_term>
    <mesh_term>Emergence Delirium</mesh_term>
    <mesh_term>Emergencies</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

